Regular Reminding of the Potential Serious Complications of Poor Adherence to Treatment: A Strategy for Improving Treatment Adherence in Beta-Thalassemia Major Patients

Emami Zeydi, Amir; Heydari, Abbas; Karimi Moonaghi, Hossein

doi:10.22038/ijp.2017.25718.2190

Regular Reminding of the Potential Serious Complications of Poor Adherence to Treatment: A Strategy for Improving Treatment Adherence in Beta-Thalassemia Major Patients

Authors

Amir Emami Zeydi ¹

Abbas Heydari ²

Hossein Karimi Moonaghi ²

¹ Student Research Committee, PhD candidate in Nursing, Department of Medical-Surgical Nursing, School of Nursing and Midwifery, Mashhad University of Medical Sciences, Mashhad, Iran.

² Evidence-Based Caring Research Center, Department of Medical-Surgical Nursing, Mashhad University of Medical Sciences, Mashhad, Iran.

10.22038/ijp.2017.25718.2190

Abstract

Globally, β-Thalassemia Major (β-TM) is the most commonly inherited hemolytic anemia, with a high incidence rate in Southeast Asia, the Middle East and Mediterranean countries. Patients with β-TM require lifelong adherence to their distressing treatment regimens, including regular blood transfusions and daily chelation therapy.

Keywords

Adherence

Beta-Thalassemia

Chelation therapy

Iron overload